Clinical Trials Logo

Clinical Trial Details — Status: Withdrawn

Administrative data

NCT number NCT04490382
Other study ID # Pro00102757
Secondary ID
Status Withdrawn
Phase N/A
First received
Last updated
Start date September 20, 2020
Est. completion date May 31, 2022

Study information

Verified date December 2020
Source Duke University
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The purpose of this study is to investigate how leg amputee patients can feel sensations with neuromodulation while they are using a prosthetic leg. "Neuromodulation" is the process by which the nervous system can be regulated by targeted delivery of a stimulus, such as electrical stimulation or chemical agents, to specific neurological sites in the body. In this study, the investigators plan to use either electrical stimulation of the spinal cord (Spinal Cord Stimulation) or electrical stimulation of the dorsal root ganglion (DRG stimulation) as methods for neuromodulation. Participation in this study will involve visiting the K-Lab (Human Performance Laboratory) at Duke's Sports Medicine Institute once prior to trial implant surgery, if feasible, and four times during the two weeks following the implantation of trial stimulation leads to evaluate sensations related to touch and position of the prosthetic leg as they are generated by neuromodulation.


Recruitment information / eligibility

Status Withdrawn
Enrollment 0
Est. completion date May 31, 2022
Est. primary completion date May 31, 2022
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria: - Subject is at least 18 years of age - Subject is able and willing to comply with the schedule and protocol - Subject is a lower limb amputee who uses a prosthetic leg - Subject is a good candidate for implantation of a stimulator for their amputation related pain - Subject has stable neurological/cognitive function in the past 30 days - Subject is able to provide informed consent Exclusion Criteria: - Subject is currently participating in a clinical investigation that includes an active treatment arm - Subject currently has an active implantable device including an Implantable Cardioverter Defibrillator (ICD), pacemaker, spinal cord stimulator, or intrathecal drug pump - Subject is a prisoner - Female subject whom are pregnant

Study Design


Related Conditions & MeSH terms

  • Somatosensory Perception Following Lower Limb Amputation

Intervention

Device:
32 channel external stimulator
Patients will be stimulated by the 32 channel external stimulator via leads placed as part of standard care neuromodulation. Then patients will undergo various tasks.

Locations

Country Name City State
n/a

Sponsors (1)

Lead Sponsor Collaborator
Duke University

Outcome

Type Measure Description Time frame Safety issue
Primary Change in stimulation as reported by patients Visit 1(baseline), visit 2(up to six hours), visit 3(up to six hours), visit 4(up to six hours)
Primary Change in stimulation parameters as measured by frequency Visit 1(baseline), visit 2(up to six hours), visit 3(up to six hours), visit 4(up to six hours)
Primary Change in stimulation parameters as measured by pulse width Visit 1(baseline), visit 2(up to six hours), visit 3(up to six hours), visit 4(up to six hours)
Primary Change in stimulation parameters as measured by amplitude Visit 1(baseline), visit 2(up to six hours), visit 3(up to six hours), visit 4(up to six hours)
Primary Change in pain score as measured by McGill Pain Questionnaire Visit 1(baseline), visit 2(up to six hours), visit 3(up to six hours), visit 4(up to six hours)
Secondary Change in gait parameters as measured by step frequency Visit 1(baseline), visit 2(up to six hours), visit 3(up to six hours), visit 4(up to six hours)
Secondary Change in passive movement detection as measured by external sensors Visit 1(baseline), visit 2(up to six hours), visit 3(up to six hours), visit 4(up to six hours)
Secondary Change in cortical reorganization measured by Electroencephalogram (EEG) Visit 1(baseline), visit 2(up to six hours), visit 3(up to six hours), visit 4(up to six hours)